Copernicus Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$260K	–	15
2020 Q4	$260K	Buy	+2,000	New	+$260K	4.05%	14